Corindus Vascular Robotics (CVRS) Earning Favorable Media Coverage, Analysis Finds
Media headlines about Corindus Vascular Robotics (NYSE:CVRS) have been trending positive recently, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Corindus Vascular Robotics earned a news sentiment score of 0.28 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 46.8098980330524 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Shares of Corindus Vascular Robotics (NYSE:CVRS) traded down 7.26% during midday trading on Wednesday, reaching $1.66. 1,047,489 shares of the company were exchanged. Corindus Vascular Robotics has a 52 week low of $0.40 and a 52 week high of $2.25. The firm has a 50-day moving average of $1.76 and a 200 day moving average of $1.21. The firm’s market capitalization is $310.55 million.
About Corindus Vascular Robotics
Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.
Receive News & Ratings for Corindus Vascular Robotics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.